project id: TCGA-STAD; case submitter id: TCGA-RD-A7C1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.02; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 7.3; age at index: 82; days to birth: -30171; days to death: 507; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1923; year of death: 2006; age at diagnosis: 30171; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2771; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-RD-A7C1-01A-11; percent lymphocyte infiltration: 18.0; percent monocyte infiltration: 3.0; percent necrosis: 20.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 65.0; percent tumor nuclei: 75.0;